Medical Oncology

Metastatic melanoma: Is biochemotherapy the future?
pp. 101-111(11)
Authors: Alexandrescu, Doru; Dutcher, Janice; Wrnik, Peter

Involvement of the epstein-barr virus in the nasopharyngeal carcinoma pathogenesis
pp. 113-121(9)
Author: Burgos, Javier

Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer
pp. 123-128(6)
Authors: Kosmas, Christos; Tsavaris, Nicolas; Soukouli, Georgia; Gouveris, Panagiotis; Tsakonas, George; Katselis, John; Alexopoulos, Heraklis; Mylonakis, Nicolas; Karabelis, Athanasios

In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7
pp. 129-138(10)
Authors: Roomi, M.; Ivanov, Vadim; Kalinovsky, Tatiana; Niedzwiecki, Aleksandra; Rath, Matthias

The value of serum Bcl-2 levels in advanced lung cancer patients
pp. 139-143(5)
Authors: Tas, Faruk; Duranyildiz, Derya; Oguz, Hilal; Camlica, Hakan; Oral, Ethem; Yasasever, Vildan; Topuz, Erkan

A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer
pp. 145-151(7)
Authors: Kallab, Andre; Nalamolu, Yasolatha; Dainer, Paul; Jillella, Anand

Irinotecan plus cisplatin combination against metastatic gastric cancer: Phase II study
pp. 153-160(8)
Authors: Altinbas, Mustafa; Er, Ozlem; Ozkan, Metin; Solak, Yusuf; Coskun, H.; Kucuk, Can; Gursoy, Sebnem

Anemia in cervical cancer patients: Implications for iron supplementation therapy
pp. 161-168(8)
Authors: Candelaria, Myrna; Cetina, Lucely; Dueñas-González, Alfonso

Hypocellular myelodysplastic syndromes: Clinical and biological significance
pp. 169-175(7)
Authors: Marisavljević, Dragomir; Čemerikić, Vesna; Rolović, Zoran; Bošković, Darinka; Čolović, Milica

Apoptosis of lymphocytes in peripheral blood of patients with melanoma
pp. 177-181(5)
Authors: Tas, Faruk; Duranyildiz, Derya; Argon, Andac; Oguz, Hilal; Camlica, Hakan; Yasasever, Vildan; Topuz, Erkan

Bcl-xl expression in multiple myeloma
pp. 183-190(8)
Authors: Peeters, S.; Hovenga, S.; Rosati, S.; Vellenga, E.

Treatment of a patient with a nodal peripheral T-cell lymphoma (Angioimmunoblastic T-cell lymphoma) with a human monoclonal antibody against the CD4 antigen (HuMax-CD4)
pp. 191-194(4)
Authors: Hagberg, H.; Pettersson, M.; Bjerner, T.; Enblad, G.

Randomized, open label, prospective study on the effect of zoledronic acid on the prevention of bone metastases in patients with recurrent solid tumors that did not present with bone metastases at baseline
pp. 195-201(7)
Authors: Mystakidou, Kyriaki; Katsouda, Emmanuela; Parpa, Efi; Kelekis, Alexis; Galanos, Antonis; Vlahos, Lambros

Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma
pp. 203-206(4)
Authors: Kurt, Mevlut; Onal, Ibrahim; Elkiran, Tamer; Altun, Bulent; Altundag, Kadri; Gullu, Ibrahim

Plasmacytoma of the lung: An indolent disease resistant to conventional myeloma treatment: Report of a case
pp. 207-210(4)
Authors: Marisavljević, D.; Marković, O.; Čemerkić-Martinović, V.; Ponomarev, D.